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ABSTRACT 
Objective: Quercetin is therapeutically hampered because of its poor solubility. The present investigation was aimed to prepare quercetin loaded 
nanosponges topical gel to enhance the solubility and efficacy of the drug.  
Methods: Quercetin nanosponges were prepared by emulsion solvent diffusion method. Developed nanosponges optimized by particle size, SEM, 
entrapment efficiency, FT-IR, DSC, P-XRD, In vitro studies. The optimized formulation of nanosponges was loaded into a topical gel and it was 
characterized by ex-vivo, in vivo Pharmacodynamic and kinetic studies. 
Results: The particle size and zeta potential of optimized nanosponges were found to be 188.3 nm and-0.1mV. Surface morphology was studied 
using SEM Analysis which showed tiny sponge-like structure and entrapment efficiency was found to be 96.5 %. In vitro drug release of optimized 
nanosponges was found to be 98.6% for 7hours. Optimized nanosponges entrapped gel was prepared by using carbopol 934 and hydroxypropyl 
methylcellulose as gelling agents. The prepared nanogels were homogenous and ex-vivo skin permeation studies of the optimized nanosponges gel 
was found to be 98.1% for 5 h, quercetin loaded nanosponges has shown higher skin permeation efficiency (18.4µg/cm2±2.1) compared to pure 
quercetin gel. The pharmacokinetic and pharmacodynamic studies showed that the quercetin loaded nanosponges has shown more effective when 
compared to marketed formulation. 
Conclusion: Quercetin loaded nanosponges gel has shown a significant increase in activity (p<0.05) compared to the marketed formulation 
(Voveran Emulgel). 
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The plant and plant parts are used for therapeutic properties like 
Dacus carota, Ocimum sanctum, Curcuma domestica valet on, 
Glycyrrhiza glabra, Foeniculum vulgar, Cuscuta reflexa and Withinia 
sommifera were known as the best examples for anti-inflammatory, 
antidiabetic, and anti-hypercholesterolemia [Soon am park et al.; 
2013, Wang Q et al.;2018]. Flavonoids are a group of plant metabolites 
found in a variety of fruits and vegetables, which are 15 carbon atom 
phenolic molecules. Quercetin is one of the vital bioflavonoid present 
in more than twenty plant materials which is known for its therapeutic 
activities like anti-inflammatory, antihypertensive, antidiabetic, 
antioxidant and anti-obesity [Qi Tan, Weidong Liu, et al.;2011]. 
Quercetin name was derived from the Latin word quercetum means 
oak forest belonging to the class flavanols. Quercetin is chemically 2-
(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one, having one 
OH group attached at positions 3, 5, 7, 31, and 41 positions [Soheirn. 
abdel rehaman et al. 2014]. Quercetin is yellow in color which is 
sparingly soluble in water and completely soluble in alcohol, which 
belongs to BCS class II drugs [Chen-Yu G et al.; 2012]. It is also 
available as an abundant dietary supplement present in the red 
grapes, onions, buckwheat, bark, olive oil, green tea, red wine, 
cranberries [Gulian quan et al.:2015]. Quercetin has a most 
remarkable property of anti-inflammatory conditions as it stops the 
formation of prostaglandins, cyclooxygenase (COX) as well as 
histamine release. Quercetin is mostly consumed orally, but the 
drawback is that it has low oral bioavailability [7]. The absorption of 
quercetin was low in the gastrointestinal tract due to its poor 
solubility. Quercetin was enzymatically hydrolyzed and it was 
glucuronidated or converted into the sulfated form of quercetin when 
taken orally [8]. The bioavailability of this quercetin was nearly 44 % 
when taken orally because most of the drug metabolized by the liver 
and is eliminated from the intestinal cells through an efflux 
mechanism [8]. So the topical drug delivery system has the advantage 
to overcome these problems [9]. The structure and composition of the 
drug were the major barriers for this type, but the formulation of the 
polymer type drug delivery can overcome this problem [10, 11]. 
Nanosponge has a 3-dimensional structure with tiny channels and 
mesh-like structure on the surface, when the solution is mixed with 
the polymers it forms a mesh-like structure, with naturally 
biodegradable polymer as the backbone which results in the formation 
of pockets like structure in which drug can be loaded [12]. Physically 
these nanosponges are in the form of dry powder which can be 
formulated as orally, topically and parentally. A wide variety of drugs 
can be loaded into the nanosponges but the drug molecular weight 
should be less than 400 daltons [13]. Nanosponges due to its nano size 
can be successfully incorporated into the topical gel, effectively 
releases the drug with increased stability, bypasses the first pass 
metabolism and reduces the gastric irritation. Due to its small size, 
they can freely circulate into the blood until they get attached to the 
specific target site. Hence the objective of the present study is to 
increase the solubility of poorly aqueous soluble quercetin by 
formulating quercetin into nanosponges. Quercetin containing 
nanosponges loaded into the gel was characterized by in vitro drug 
release, in vivo pharmacokinetic and pharmacodynamic studies. 
MATERIALS AND METHODS 
Materials 
Quercetin, Ethylcellulose, Polyvinyl alcohol was purchased from SD. 
Fine-chemicals Ltd, Dichloromethane was purchased from Merck 
limited, Mumbai, Hydroxypropyl methylcellulose (HPMC), Carbopol 
934, HPLC methanol was purchased from HiMedia. Triethanolamine, 
Glycerine and Methylparaben and Propylparaben have purchased 
from Merck limited, Mumbai. Microorganisms (Staphylococcus aureus, 
E. coli, Proteus vulgaris, Bacillus subtilis) obtained from HiMedia.  
Methods 
Preparation of quercetin-loaded nanosponges 
Quercetin loaded nanosponges were formulated by using the 
emulsion solvent diffusion method using ethyl cellulose as polymer 
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and quercetin as a drug. Required quantities of the drug and 
polymer were added into the solvent dichloromethane and mixed 
well. The above solution was added into the external aqueous phase 
containing required quantities of polyvinyl alcohol and 150 ml of 
water [14, 15] in a continuous stirring process at 1200 rpm for 30 
min on a magnetic stirrer. The formed nanosponges were filtered 
and dried in the oven. The formulation composition of quercetin-
loaded nanosponges was given in table 1. 
 
Table 1: Formulation composition of quercetin-loaded nanosponges 
S. No. Formulation code Drug: Ethyl cellulose (mg) PVA(mg) Water(ml) 
1 F1 1:1 100 150 
2 F2 1:2 100 150 
3 F3 1:3 100 150 
4 F4 1:4 100 150 
5 F5 1:5 100 150 
6 F6 1:4 100 200 
7 F7 1:4 100 300 
8 F8 1:4 150 150 
9 F9 1:4 200 150 
 
Quercetin loaded nanosponges gel 
A nanosponge showing a high percentage of drug release F4 was 
converted into a topical gel using polymers carbopol 934 and 
hydroxypropyl methylcellulose (HPMC). Carbopol934 and 
hydroxypropyl methylcellulose [16] were weighed and soaked for 
24h in the required quantity of water and stirred using a mechanical 
stirrer at 1000 rpm [16, 17]. In the above-formed gel required 
quantities of glycerin, methylparaben, propylparaben, and 
triethanolamine were added with continuous and slow stirring for 
30 min. Composition of quercetin-loaded nanosponges gel was given 
in table 2. 
 
Table 2: The composition of topical gels using different concentrations of polymers (Carbopol 934 and HPMC) 
 S. No. Formulation code  Composition Ratios of polymers 
 1 X1 Carbopol: HPMC 1:1 
2 X2 Carbopol: HPMC 1:2 
3 X3 Carbopol: HPMC 1:3 
4 X4 Carbopol: HPMC 1:4 
5 X5 Carbopol: HPMC 2:1 
6 X6 Carbopol: HPMC(pure) 1:1 
 
Evaluation of quercetin-loaded nanosponges 
Scanning electron microscopy 
Scanning electron microscopy (JOEL-JSM-IT500) was used for 
surface morphology and structural elucidation of the formed 
nanosponges. The formed images were captured, particles size and 
surface morphology were studied [18, 19]. 
Particle size and zeta potential 
The particle size and zeta potential of the formed quercetin loaded 
nanosponges were determined by using the Horiba zeta sizer [20]. 
The dispersion was mixed, thoroughly diluted with water and then 
analyzed. Each sample was analyzed in triplicates and the average of 
the three values was noted. 
Differential scanning calorimeter 
Differential scanning calorimeter (Metler Toledo, Switzerland) 
studies were done to find out the chemical compatibility between 
the polymers and drug. For this, the melting point of the pure drug 
was compared to the melting point of the drug in the formulation 
[21, 22]. The instrument was calibrated with tin as standard 
material. 5 mg of the sample was taken in an aluminum crucible and 
heated at a rate of 10 °C in the temperature range of 100-300 °C.  
X-ray diffraction studies 
The crystalline nature of the drug in the pure quercetin and 
quercetin loaded nanosponges was evaluated by using these P-XRD 
studies [23, 24]. Powder X-ray diffractometer (Regaku-mini plus 
500) was done by using k-beta (x2) filtered, Cu–k, alpha 
radiation, and at a voltage of 30kv, and 15 mA. 
Drug compatibility with excipients 
Drug compatibility study of pure quercetin, ethylcellulose, and 
nanosponges formulated using quercetin was carried out by 
potassium bromide pellets by applying pressure of 100 kg to form a 
pellet [25, 26]. They formed pellet was scanned in the region of 4000-
600 cm-1 using (FTS300 Spectrophotometer (Glab), Canton, MA). 
Entrapment efficiency 
The amount of quercetin present in the quercetin loaded 
nanosponges was determined by taking 10 mg of quercetin-loaded 
nanosponges in 10 ml of phosphate buffer pH 7.4 and kept aside for 
24h and then after 24h the solution was stirred using a magnetic 
stirrer (Remi equipment, Mumbai) at 1000 rpm for 30 min and 
filtered. The filtered solution absorbance was measured by using a 
UV visible spectrophotometer (Shimadzu, Japan) at 372 nm. 
In vitro drug release studies 
The release rates of quercetin-loaded nanosponges were 
investigated using the dialysis membrane, which is having a pore 
size of 2.4 nm and a molecular weight of 12,000-14,000 daltons was 
used. This dialysis membrane was soaked 12 h before using in 
distilled water. 100 ml of phosphate buffer of pH 7.4 was taken in a 
beaker [26, 27]. The beaker was placed on a magnetic stirrer (Remi 
equipment, Mumbai) at 100 rpm and at a temperature of 37 °C. An 
aliquot of 5 ml of the sample was taken at regular intervals; an equal 
amount of fresh buffer was replaced in the beaker to maintain sink 
conditions [28]. The samples were measured using UV-visible 
spectrophotometer (Shimadzu, Japan) at a wavelength of 372 nm. 
Characterization of quercetin-loaded nanosponges gel 
Physical examination of gel 
The formed quercetin loaded nanosponges gel was physically tested 
for the presence of any aggregates and uniformity by visually after it 
was stored in a container. 
The pH of the gel 
The pH of the quercetin loaded nanosponges gel was determined by 
using a digital pH meter (Remi equipment, Mumbai). 
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The viscosity of the gel was determined by Brookfield LV Viscometer 
[29]. The prepared quercetin loaded nanosponges gel of 5g was 
taken in a beaker and by selecting spindle number 64 the viscosity of 
the gel was noted. 
Percentage of drug content 
10 mg of the gel was placed in 10 ml of phosphate buffer of pH 7.4 
and the solution was kept aside for 24h and the solution was stirred 
on a magnetic stirrer (Remi equipment, Mumbai) for 30 min and 
filtered [29]. The absorbance of a filtered solution was measured by 
using a UV spectrophotometer (Shimadzu, Japan) at 372 nm. 
Antimicrobial activity by a zone of inhibition method 
The 20 ml of sterilized broth was taken individually into four Petri 
dishes and inoculated with four different types of bacteria 
(Staphylococcus aureus, E. coli, Proteus vulgaris, Bacillus subtilis). The 
subcultured bacteria were spread on the solidified nutrient broth 
and four wells were kept on the solidified agar medium of 6 mm to 
place quercetin loaded nanosponges gel [30]. The Petri dishes were 
incubated at 35-37 °C for 24h. Then the zone of inhibition of 
microbial growth was measured using the scale in centimeters. 
Ex-vivo skin permeation studies and flux value determination 
The ex-vivo skin permeation studies were performed using goatskin in 
the modified Franz diffusion cell. Goatskin, which was brought from a 
local slaughterhouse, the hair on the goatskin was removed by using the 
razor and the skin was wiped with isopropyl alcohol. Goatskin was 
mounted in between donor and receptor compartment. The donor 
compartment of the diffusion cell was placed with 500 mg of quercetin-
loaded nanosponges gel and the receptor compartment was filled with 
phosphate buffer of pH 7.4 [31, 32]. The entire setting was placed on the 
magnetic stirrer (Remi equipment, Mumbai) with an rpm of 100 and 
temperature 37 °C was maintained. Then aliquot of 5 ml of the sample 
was taken at regular intervals of time 0,0.25,0.5,1,2,3,4,6,8,12,24 h and a 
freshly prepared buffer of 5 ml was placed back into the receptor 
compartment to maintain the sink conditions. The samples were 
measured using the UV spectrophotometer (Shimadzu, Japan) at 372 
nm. The obtained results were subjected for the skin permeation 
parameters like flux, permeation coefficient, lag time and diffusion 
coefficient by plotting a graph between percentage cumulative drug 
release on the y-axis and time on the x-axis. The data obtained were also 
subjected to mathematical models like zero order, first order, Higuchi, 
Korsmeyer-peppas model [33]. 
Stability studies 
According to the International Council for Harmonization of technical 
requirements for pharmaceutical for human use (ICH) guidelines, the 
stability studies of the prepared quercetin loaded nanosponges gel and 
quercetin pure gel were conducted. The prepared gels were studied 
under two variations 25±2 °C (refrigerator temperature) and 40±2 
°C (accelerated stability condition) for a period of three months [34, 35]. 
Parameters like pH, drug content, homogeneity, in vitro drug release 
studies were conducted. 
In vivo anti-inflammatory activity 
Anti-inflammatory activity studies were carried in male Wistar rats. 
Animals were procured from Sri Venkateswara Enterprises, 
Bangalore. The animals were housed under the standard 
environmental conditions like humidity (55±5%) ambient 
temperature (25±1 °C) and 12/12h dark and light cycles. All the 
protocols and experimental procedures which were used for the 
anti-inflammatory study were as per the guidelines of a committee 
for the purpose of control and supervision of experiments on 
animals (CPCSEA) and which was approved by institutional animal 
ethics committee bearing Reg. No.1677/PO/Re/ 
S/2012/CPCSEA/IAEC/25 dt.3.05.2018. The in vivo pharmaco-
dynamic activity was performed to find out the efficacy of the 
quercetin loaded nanosponges gel in animals. For this study male 
Wistar albino rats were used. They were grouped into five and all 
the animals were kept at an optimum weight of 150-200g and age of 
10-12 w [35, 36]. Group I was treated as the control without any 
treatment, Group II was normal with only carrageenan (1%w/v) 
inducer, Group III was treated with marketed Voveran gel, Group IV 
with pure quercetin gel and Group V with quercetin loaded 
nanosponges gel. Carrageenan solution (1%w/v in normal solution) 
was used as an inducer to produce inflammation. The animals were 
kept in observation for 10 min for any behavioral changes. The 
thickness of the paw was measured (mm) at regular time intervals 
as 0,30 min,1hr,2hr,3hr,4hr after inducing carrageenan to plantar 
region of the left hind paw, quercetin loaded nanosponges gel and 
pure quercetin gel was applied to the sole of the paw where the 
inflammation was induced. The paw volume was noted using 
plethysmometer [37]. The percentage of inhibition of paw volume of 
rats was calculated by using the formula. 
% inhibition of edema = V control- V test/V control 
In vivo pharmacokinetic study 
Pharmacokinetic parameters were done to estimate the 
concentration of the drug in the blood. Three groups of rats were 
taken each group containing randomly six rats, which were housed 
under normal conditions; the rats were fastened overnight before 
the experiment with free access to water. The study was conducted 
with three groups Group I control, Group II for the pure quercetin 
gel and Group III for quercetin loaded nanosponges gel. Drug 
concentration was estimated by RP-HPLC method using methanol: 
orthophosphoric acid (65:35) as a mobile phase, with glibenclamide 
an internal standard and C18 as a column having dimensions 
(4.6x250 mm, 5 µm) (Shimadzu, Japan) with a flow rate of 0.8 
ml/min [38,39]. Blood samples were collected at different time 
intervals from male Wistar albino rats from retro-orbital into 
Eppendorf tubes containing sodium citrate as an anticoagulant.  
Treatment of plasma samples 
The working solution containing the plasma samples spiked with 
various concentrations of the quercetin with a fixed amount of internal 
standard was transferred into a clean centrifugation tube. To this 400 µl 
of methanol was added which acts as a protein precipitant and the 
solution was vortex mixed and centrifuged at 5000 rpm (Remi 
equipment, Mumbai) for five minutes. The supernatant solution was 
separated and injected into an HPLC column using a Hamilton syringe 
and analyzed at the wavelength of 372 nm [40]. 
RESULTS AND DISCUSSION 
Scanning electron microscopy 
The photographs of quercetin-loaded nanosponges using scanning 
electron microscope are shown in fig. 1(a) to fig. 1(c). The formed 
nanosponges were spherical in shape with tiny mesh-like structure. 
The size and shape were unaffected even after encapsulating the 
quercetin drug in the nanosponges. 
Particle size and zeta potential 
All measurements were performed in triplicates for measuring the 
size and zeta potential of the particles at a temperature of 25±2 °C 
[20]. The dispersions were diluted by using double distilled water 
to ensure that scattering of light was within the range of 
sensitivity. The average particle size of the optimized nanosponges 
was found to be 188.3 nm with a polydispersity index of 0.13, 
which indicates that it has a homogenous particle distribution. 
Homogeneity of the particles was measured by the polydispersity 
index, which varies from 0 to 1 the value closer to zero indicates 
more homology between the particles. Zeta potential of the 
optimized nanosponges was found to be-0.1mV. This indicates that 
the formed quercetin loaded nanosponges were stable through 
electrostatic repulsion and thereby avoiding the repulsion 
between the particles. The concentration of the polymer plays an 
important role in the size of the nanosponges from F1 to F5 (1.1 
nm, 17.9 nm, 18.2 nm, 188.3 nm, 289.9 nm) as the concentration of 
the polymer increases with respect to the drug the size of the 
nanosponges increases. Thus polymer and drug ratio plays an 
important role in particle size analysis. The zeta size fig. 2(a) and 
potential for F1 to F5 (-22.0mV,-11.9mV,-18.3mV,-0.1mV,-3.6mV) 
was shown in fig. 2(b). 
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Fig. (1a, 1b, 1c): Scanning electron microscopy images 
 
 
(a)     (B) 
Fig. (2a, 2b) Zeta size and zeta potential 
 
Differential scanning calorimetry (DSC) 
The Differential scanning calorimetry (DSC) thermograms showed 
that compatibility between polymer and drug. The thermograms 
showed the melting point range of 303.6 °C for pure quercetin drug 
and 297.85 °C for the quercetin loaded nanosponges. Both the peaks 
in thermogram are same, which showed that quercetin loaded 
nanosponges have the same crystalline state of quercetin in pure 
form [22]. The DSC thermograms of pure quercetin fig. 3 (a) and 
quercetin loaded nanosponges were shown in the fig. 3(b). 
X-Ray diffraction studies 
P-X-ray diffractograms of the pure quercetin and the quercetin 
loaded nanosponges were taken and analyzed [24]. The 
diffractograms of the pure quercetin showed 2Ө values as follows 
(12.46,14.14,15.73,16.43,18.14,19.9,20.8,25.05,27.8,28.4,30.8). This 
implies that the drug has high crystalline nature and the quercetin 
loaded nanosponges also show similar 2Ɵ values in quercetin loaded 
nanosponges, they both exhibit the same intense sharp peaks. Which 
indicates the crystalline nature of the quercetin was not lost in the 
quercetin loaded nanosponges when compared to the pure form. 
The slight difference is only due to the reduction in size, which 
implicates the enhancement in the dissolution and solubility of the 
nanosponges. X-ray diffractogram of pure quercetin fig. 4(a) and 
quercetin nanosponges were shown in fig. 4(b). 
Drug-excipient compatibility study 
Fourier infrared spectroscopy (FT-IR) was one of the most quickened 
and efficient identifiers of the encapsulated chemical molecules [15]. 
The characteristic peak intensities of pure quercetin molecules are as 
follows it shows O-H stretching at 3400 cm-1,=C-H stretch at 2930 cm-1, 
C=O stretching at 1680 cm-1, aromatic C=C stretch at 1510 cm-1 and 
1610 cm-1 and aromatic C-O stretch at1220 cm-1. The pure quercetin 
drug and the quercetin loaded nanosponges have shown the same 
characteristic peaks which implicate there is no chemical interaction 
between the polymer and drug. An (FT-IR) Fourier infrared 
spectroscopy spectrum of pure quercetin fig. 5(a), ethylcellulose fig. 
5(b) and optimized quercetin nanosponges were shown in fig. 5(c). 
 
Quercetin pure drug (3a) 
 
Quercetin loaded nanosponges (3b) 
Fig. (3a, 3b): DSC differential scanning calorimetry 
thermograms 
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Diffractogram of pure quercetin (4a) 
 
Diffractogram of quercetin loaded nanosponges (4b) 
Fig. 4: X-ray diffractogram of pure quercetin (4a), quercetin loaded nanosponges (4b) 
 
Entrapment efficiency 
Entrapment efficiency was measured for all the formulations from 
F1-F9 the amount of drug entrapped in the nanosponges was found 
to be in the range of 90-97% from F1-F5 as the drug entrapped was 
reduced from F6-F9 this is because as the volume of water and the 
quantity of polyvinyl alcohol was increased the nanosponges formed 
were irregular in size and shape and lead to the formation of 
aggregates and entrapment efficiency is also decreased. 
Formulations from F6-F9 were discarded for further studies as their 
entrapment efficiency is very low. The entrapment efficiency of 
various formulations from F1-F9 was tabulated in table 3. 
 
Table 3: Entrapment efficiency of quercetin loaded nanosponges 
S. No. Formulation Entrapment efficiency (%) Zeta size(nm) Zeta potential (mV) 
1 F1 96±1.3 1.1 -0.1 
2 F2 98±1.67 17.9 -22.0  
3 F3 100±2.5 18.2 -18.3  
4 F4 98±1.3 188.3 -11.9  
5 F5 97±1.4 289.9 -3.6  
6 F6 23.5±1.1 - - 
7 F7 9.5±0.99 - - 
8 F8 15±2.13 - - 
9 F9 10±0.51 - - 
The values are given as mean±SD, n=3 
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Pure quercetin (5a) 
 
Ethyl cellulose (5b) 
 
Quercetin loaded nanosponges (5c) 
Fig. (5a, 5b, 5c): Fourier transform infrared spectroscopy 
 
In vitro release studies 
In vitro release studies were done by using a phosphate buffer of pH 
7.4. All the formulations of nanosponges were subjected to in vitro 
drug release studies by using a dialysis membrane. The formulation 
F4 has shown the maximum cumulative percentage of drug release 
98.6% for 7h; the F4 has shown the highest release in 7 h when 
compared to all other formulations. The cumulative drug release 
profile was obtained by taking time on x-axis and % cumulative 
percent of drug release on the y-axis [11]. The release studies were 
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performed for all the formulations F0 (Pure drug), F1, F2, F3, F4, F5. 
The amount of drug release was found to be 98% for formulation F4 
in 7h, for F3 it is 90.5%in 6h, F2 70%, F1 63.5%, F5 79.4% and pure 
drug 39% at the end of 7h. When compared from F0-F5, the F4 has 
shown the highest drug release when compared to all other 
formulations this may be accredited because of the high solubility of 
the drug. The optimized F4 formulation followed the zero-order 
drug release profile. Percentage cumulative drug release profile 
from F0-F5 was given fig. 6. The concentration of polymer played an 
important role in the release characteristics. 
 
 
Fig. 6: Comparative in vitro dissolution profile of different quercetin loaded nanosponges formulations, mean±SD, n=3 
 
Characterization of quercetin-loaded nanosponges of gels 
The prepared gels were homogenous and they exhibit no aggregates, 
they were transparent in nature and smooth in appearance. The 
physicochemical properties like pH, viscosity and drug content of the 
formulated gels were calculated and tabulated in table 4 [9]. All the 
prepared gels from X1-X6 has shown a pH range of 6.8-7.0. This is 
considered as acceptable ranges to reduce the skin irritation. The 
viscosity of the gels plays an important role in the extrudability and the 
release of the drug. Gels with high viscosity may not extrude that easily 
from the tube and low viscous gels may flow easily from the tube that is 
the reason there should be an optimum viscosity for the gels. The 
viscosity of the formed gels ranges from 8,300-48,700cps, the viscosity 
variation was due to change in the concentrations of the polymers 
(carbapol934 and hydroxypropyl methylcellulose) as the concentration 
of the polymer hydroxyl propyl methyl cellulose increased there was an 
increase in the viscosity of the gel. The drug content of the gels from X1-
X6 was found to be in the range 95-98% and given in table 4. 
 
Table 4: Evaluation of physicochemical properties of quercetin loaded nanosponges gel 
S. No. Carbopol 934:HPMC Viscosity (cps) Appearance Drug content (%) pH 
1 X1 8,300 Homogenous 98.5±0.69 7.0±0.2 
2 X2 8,900 Homogenous 96.5±1.38 7.0±0.1 
3 X3 10,200 Homogenous 95.2±0.87 7.0±0.2 
4 X4 24,560 Homogenous 97.4±3.54 6.8±0.3 
5 X5 48,745 Homogenous 94.2±2.5 7.0±0.15 
6 X6 8,640 Homogenous 96.2±0.53 7.0±0.53 
 The values are given as mean±SD, n=3 
 
    
Staphylo coccus aureus Bacillus subtilis Proteous vulgaris Escherechia coli 
Fig. 7: Antimicrobial effect of quercetin-loaded nanosponges gel against bacteria Staphylococcus aureus, Bacillus subtilis, Proteus vulgaris, 
Escherichia coli studies by a zone of inhibition method 
 
Antimicrobial activity by a zone of inhibition method 
This study was determined by using the bacterial strains 
Staphylococcus aureus, Escherichia coli, Proteus vulgaris, Bacillus 
subtilis obtained from HiMedia. The antimicrobial activity was 
carried out for optimized formulation X1 quercetin loaded 
nanosponges gel [13]. The gel showed that they were 
microbiologically inert towards the bacterial strains. The zone of 
inhibition was reported for Staphylococcus aureus was 2.9 cm2, 
Escherichia coli was 3.2 cm2, Proteus vulgaris was 3.0 cm2 and 
Bacillus subtilis was 3.4 cm2 were represented in fig. 7. 
Ex-vivo skin permeation studies and flux value determination 
The quercetin loaded nanosponges gel and pure quercetin gel were 
subjected to ex-vivo skin permeation studies using goatskin. The 
amount of drug permeated through the goat skin into the receptor 
compartment was measured by taking the samples at regular 
intervals of time [32]. Among all the formulations, the cumulative 
percent of drug permeated through the skin for the optimized X1 gel 
loaded with F4 formulation was found to be 95% for four hours and 
the cumulative percentage of drug release for pure quercetin gel X6 
it showed 50% for 24h. The cumulative percent of drug diffused was 
given in (fig. 8). Highest ex-vivo skin permeation from X1 may be 
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attributed due to the increased solubility of the drug within the gel 
matrix into the test media. The permeation parameters were 
calculated from a graph by plotting the cumulative percent drug 
release on the y-axis versus time on the x-axis. The flux was 
calculated from the slope of the graph and was found 
as18.4µg/cm2/h for quercetin nanosponges and 10.3µg/cm2/h for 
pure quercetin and the flux value was more for quercetin 
nanosponges than pure quercetin gel. The lag time, permeation 
coefficient, diffusion coefficient was calculated for quercetin 
nanosponges gel and pure celecoxib gel and the values are as follows 
(0.03, 0.98h) (3.12, 2.1 kg) (0.0234, 0.16 mol/m3). The data obtained 
from the ex-vivo skin permeation studies were subjected to the 
kinetic data modeling to find out the release mechanism studies 
from the quercetin loaded nanosponges gel. From the fig. 8 and it 
was found that the nanosponges loaded quercetin gel release follows 
zero-order mechanism which governs the release of the drug. From 
the equation R2=0.99, the drug release follows the Higuchi model 
which indicates it follows the diffusion mechanism (fickian n<0.5). 
The quercetin loaded nanosponges gel showed the best release 
when compared to pure quercetin gel.  
Stability studies 
The studies were performed as per ICH guidelines for the optimized 
F4 formulation which was converted into a polymer-based topical gel. 
The physical appearance of this gel was observed it does not show any 
variations and they appear smooth, uniform distribution without any 
aggregate formation for a period of three months. This implies that the 
formed quercetin loaded nanosponges gel and pure quercetin gel were 
stable. The percentage of drug content, in vitro drug release studies, 
shows no significant change in the drug content and percent of drug 
release. It was concluded that optimized formulation (X1) and pure 
quercetin gel were stable during the period of 3 mo of stability studies. 
The results were tabulated in table 5. 
 
 
Fig. 8: Ex-vivo skin permeation studies of pure quercetin gel and 
quercetin loaded nanosponges gel 
 
Table 5: Stability studies for the optimized quercetin loaded nanosponges gel 
Temperatures 25±2 °C 40±2 °C 
Time in days pH Drug 
content  








7.0±0.1 98.5 Smooth and 
transparent 
98.6 % 7.0±0.2 97.5 Smooth and 
transparent 
98.6% 
30 d  7.0±0.2 98.5 Smooth and 
transparent 
97.2 % 7.0±02 97.5 Smooth and 
transparent 
97.2% 
60 d  6.9±0.1 97.8 Smooth and 
transparent 
97.2 % 6.8±02 96.9 Smooth and 
transparent 
97.2% 
90 d 6.8±0.2 97.6 Smooth and 
transparent 
97.0 % 6.7±0.3 96.9 Smooth and 
transparent 
97.0% 
The values are given as mean±SD, n=3.  
 
Pharmacodynamic studies 
Anti-inflammatory activity was carried out using carrageenan-
induced paw edema method. For quercetin loaded nanosponges gel 
and pure quercetin gel. For this study male, Wistar albino rats were 
selected which were grouped into five, each group containing six 
animals, weighing 150-200g. The anti-inflammatory test results are 
as follows the percentage inhibition of paw volume for Group III was 
76.2%, Group IV 40.4% and Group V 96.4% which is indicated in the 
fig. 9. From the results, it is evident that there is a significant 
difference (*p<0.005) between the pure quercetin gel and quercetin 
loaded nanosponges gel. The data were subjected to ANOVA (Graph 
Pad Prism, software), it was found that the F ratio was 3.0 (fc<ft). So 
there is a significant difference between the pure quercetin and 
quercetin loaded nanosponges gel. Quercetin loaded nanosponges 
gel shows effective inhibition when compared to the marketed gel 
and pure quercetin gel (quercetin loaded nanosponges 
gel>marketed gel>pure quercetin gel). 
 
 
Fig. 9: Percent edema inhibition of quercetin loaded nanosponges gel, marketed gel and pure quercetin gel, P<0.05 compared with 
disease control values were expressed as mean±SEM observation, ANOVA (FC>ft) there is a significant difference 
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The current analytical method as mentioned above was applied for 
the study of pharmacokinetic parameters of pure quercetin and 
quercetin loaded nanosponges gel. The chromatogram of quercetin 
showing retention time of 7.6 having internal standard 
(glibenclamide) peak at 3.1 was shown in fig. 10. The mean plasma 
concentration versus time profile of pure quercetin gel and 
quercetin loaded nanosponges gel after topical administration of 
both the gels were summarized as follows C max (15.5, 27.05µg/ml), 
T max (4,2h), t1/2(10, 9.7h), AUC (90,126 µg/ml) as follows. The mean 
plasma concentration (AUC), C max, T max, t1/2 was statistically 
significant (*p<0.05) when compared to the pure quercetin gel and 
quercetin loaded nanosponges gel. Pure quercetin gel and quercetin 
loaded nanosponges gel which is given fig. 11. Quercetin loaded 
nanosponges gel has shown fast absorption with C max (27.05µg/ml) 
and more AUC (126 µg/ml) as it contains the tiny size of 
nanosponges (188.3 nm) which makes the drug more permeable 
when compared to pure quercetin gel through the skin. 
  
 
Fig. 10: HPLC chromatogram of quercetin 
 
 
Fig. 11: Plasma concentration time profile of pure quercetin gel and quercetin nanosponges gel in rats n=6, Data presented as mean±SD 
 
CONCLUSION 
From above all the results it can be concluded that the nanosponges 
prepared with ethyl cellulose and drug quercetin by emulsion 
solvent diffusion method were effectively incorporated into the 
topical gel. The quercetin loaded nanosponges gel showed more for 
anti-inflammatory activity when compared to pure quercetin gel and 
marketed Voveran Emulgel.  
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